The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 18 September 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 343K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sze, D. M.-Y.
Right arrow Articles by MacLennan, I. C.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sze, D. M.-Y.
Right arrow Articles by MacLennan, I. C.M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2000/9/813/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 6, September 18, 2000 813-822


Original Article

Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival

Daniel M.-Y. Szea, Kai-Michael Toellnera, Carola García de Vinuesaa, Dale R. Taylora, and Ian C.M. MacLennana

a University of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
University of Birmingham/MRC Centre for Immune Regulation, Birmingham B15 2TT, UK.44-121-414-359944-121-414-4068

i.c.m.maclennan{at}bham.ac.uk

B cells recruited into splenic antibody responses grow exponentially, either in extrafollicular foci as plasmablasts, or in follicles where they form germinal centers. Both responses yield plasma cells. Although many splenic plasma cells survive <3 d, some live much longer. This study shows that early plasma cell death relates to a finite capacity of the spleen to sustain plasma cells rather than a life span endowed by the cell's origin or the quality of antibody it produces. Antibody responses were compared where the peak numbers of plasma cells in spleen sections varied between 100 and 5,000 cells/mm2. In each response, plasmablast clones divided some five times, with the peak numbers of plasma cells produced relating directly to the number of B cells recruited into the response. The spleen seems to have the capacity to sustain between 20 and 100 plasma cells/mm2. When this number is exceeded, there is a loss of excess cells. Immunoglobulin variable region gene sequencing, and 5-bromo-2'-deoxyuridine pulse–chase studies indicate that long-lived splenic plasma cells are a mixture of cells derived from the extrafollicular and germinal center responses and cells derived from virgin and memory B cells. Only a proportion has switched immunoglobulin class.

Key Words: plasma cell survival • plasmablast growth • hypermutation • immunoglobulin class switch • spleen


Abbreviations used in this paper: BrdU, 5-bromo-2'-deoxyuridine; CGG, chicken gamma globulin; NP, (4-hydroxy-3-nitrophenyl) acetyl; QM, quasimonoclonal.

© 2000 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS